AMP-Program-170x200The Jefferson County Family Court Adolescent Mentoring Program (AMP), a grant funded program provided by the Alabama Department of Economic and Community Affairs, was founded in 2009 in Jefferson County through a partnership with UAB TASC and Jefferson County Family Court. The mission of the Adolescent Mentoring Program is to reduce juvenile delinquency by facilitating the creation of one-on-one relationships between high-risk youth and caring adults that are consistent and lasting, allowing the youth to make positive life choices that enable them to maximize their personal potential.  AMP envisions a community in which every high-risk youthful offender experiences positive one-on-one relationships and community support, which in turn allows each of them to develop into their full potential capable of making informed, responsible decisions as involved members of our community. Mentor eligibility requirements include: must reside in the Birmingham Metro area, must be at least 23 years of age, and never been accused, arrested, charged, or convicted of child abuse or molestation.


To become a mentor with AMP contact Khadidr Jones at 264-8161
or Jamie Furman at 264-8156.  Mentor training begins 
Saturday, January 30th 8am-4pm at the Grace and Truth Church (Kairos Café).

Xiaohua-Li-1-300x200The University of Alabama Board of Trustees appointed Xiaohua Li, M.D., Ph.D., to the Tate Jordan Thomas Professorship in Psychiatric Medicine at the University of Alabama at Birmingham (UAB) Department of Psychiatry and Behavioral Neurobiology at its Feb. 5 meeting.


hudseal-213x200The REACT (Research and Evaluation of Assertive Community Treatment) program headed by Harry Findley has received renewal grants as part of theU.S. Department of Housing and Urban Development (HUD) Continuum of Care program.  Read the full article here.

mlesortDr. Mathieu Lesort, Assistant Professor in the Department of Psychiatry and Behavioral Neurobiology, is leading a pilot study supported by the Department to test the hypothesis that selective and developmentally regulated post translational modifications of the Disrupted InSchizophrenia-1 gene (DISC1) tightly regulate its association with binding proteins. Schizophrenia and schizoaffective disorder are common and devastating diseases of the brain that remain poorly understood and likely result from a complex interplay between multiple factors influencing susceptibility and progression.  

cleveland kinney 2009 2Dr. Cleveland Kinney is researching an experimental drug known as bapineuzumab. UAB is participating in national and international Phase III Alzheimer’s clinical trials in which they administer the drug to patients, and there is real hope that bapineuzumab will change the underlying pathology of the disease, ultimately eradicating it from the body.